← Back to all trials
Completed
NCT05731089
IVI Aflibercept Before and After Phaco in DME.
Conditions: Diabetic Macular Edema
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 40
Sponsor: Al Hadi Hospital
Location: Kuwait
Summary
To study whether or not cataract surgery should be deferred until treating the co-existing diabetic macular edema (DME) using intravitreal (IVI) anti-vascular endothelial growth factor (anti-VEGF).
Eligibility Criteria
Inclusion Criteria:- Diabetic patients with visually significant cataractExclusion Criteria:previous vitreoretinal surgerylaser or intravitreal injections 6 months prior to the procedureintractable glaucomactive intra-ocular inflammationretinal detachmentvitreous hemorrhageepi-retinal membranesany other retinal vascular or neuroretinal disease.Patients with eventual cataract surgeries
Source: ClinicalTrials.gov (NCT05731089). StuddyBuddy aggregates publicly available trial information.
